Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
Clinical trial NCT05347771 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05347771
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-04
- Primary completion
- 2026-12-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.